Abstract
As antioxidants play a protective role in the pathophysiology of diabetes and cardiovascular diseases, understanding the physiological status of antioxidant concentration among people at high risk for developing these conditions, such as Metabolic Syndrome, is of interest. In present study out of 187 first degree non-diabetic relatives and 192 non-diabetic spouses, 33.1% and 19.7% were found to have metabolic syndrome respectively. Subjects with metabolic syndrome (≥3 risk factors) had poor antioxidants status as reflected by significantly low levels of vitamin A, C & E and significantly increased (p<0.01) oxidative stress as compared to those without metabolic syndrome. At the same time serum insulin levels and insulin resistance were found to be significantly high (p<0.001) in metabolic syndrome. A strong positive correlation (r=0.946; p<0.001) between oxidative stress and insulin resistance was observed in metabolic syndrome. Low levels of antioxidants and increased oxidative stress with insulin resistance in metabolic syndrome suggests that besides therapeutic life style changes (TLC) as suggested in ATP III guidelines inclusion of antioxidant vitamins, fruits and vegetable could be beneficial to ward off the consequences of metabolic syndrome.
Key Words: Diabetes, NIDDM, CAD, Metabolic syndrome, Insulin Resistance, Antioxidants, Oxidative Stress
Full Text
The Full Text of this article is available as a PDF (378.4 KB).
References
- 1.Oberly L.W. Free radicals and diabetes. Free Rad. Biol. Med. 1988;5:113–124. doi: 10.1016/0891-5849(88)90036-6. [DOI] [PubMed] [Google Scholar]
- 2.Halliwell B. Antioxidants and human disease: a general introduction. Nutrition Reviews. 1997;55:44–52. doi: 10.1111/j.1753-4887.1997.tb06100.x. [DOI] [PubMed] [Google Scholar]
- 3.Diaz M.N., Frei B., Vita J.A., Keaney J.F. Antioxidants and Atherosclerotic Heart Disease. The New Eng. Jour. Med. 1997;7:408–16. doi: 10.1056/NEJM199708073370607. [DOI] [PubMed] [Google Scholar]
- 4.Light D.W., Carrier M.J., Anggard E.E. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc. Res. 2000;47:457–464. doi: 10.1016/S0008-6363(00)00054-7. [DOI] [PubMed] [Google Scholar]
- 5.Asplund K. Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J. Intern. Med. 2002;251:372–392. doi: 10.1046/j.1365-2796.2002.00973.x. [DOI] [PubMed] [Google Scholar]
- 6.Isomaa B., Almgren P., Tuomi T., Foren B., Lahti K., Nissen M., Taskinen M.R., Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689. doi: 10.2337/diacare.24.4.683. [DOI] [PubMed] [Google Scholar]
- 7.Wilson P.W., Kannel W.B., Silbershatz H., D’Agostino R.B. Clustering of metabolic factors and coronary heart disease. Arch. Intern. Med. 1999;159:1104–1109. doi: 10.1001/archinte.159.10.1104. [DOI] [PubMed] [Google Scholar]
- 8.Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., Salonen J.T. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–2716. doi: 10.1001/jama.288.21.2709. [DOI] [PubMed] [Google Scholar]
- 9.Meigs J.B. Epidemiology of the metabolic syndrome. Am J. Manag. Care. 2002;8:S283–S292. [PubMed] [Google Scholar]
- 10.National Institutes of Health Executive Summary. In Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA. 2001;285(19):2486–2497. doi: 10.1001/jama.285.19.2486. [DOI] [PubMed] [Google Scholar]
- 11.Elbein S.C., Maxwell T.M., Schumacher M.C. Insulin and glucose levels and prevalence of glucose intolerance in pedigrees with multiple diabetic siblings. Diabetes. 1991;40:1024–1032. doi: 10.2337/diabetes.40.8.1024. [DOI] [PubMed] [Google Scholar]
- 12.Mayer E.J., Newman B., Austin M.A., Zhang D., Quesenberry C.P., Edwards K., Selby J.V. Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins. Am. J. Epidemiol. 1996;143:323–332. doi: 10.1093/oxfordjournals.aje.a008746. [DOI] [PubMed] [Google Scholar]
- 13.Natelson, S., Thomas, C.C. (1971) In techniques of Clinical Chemistry 3rd ed., Publisher Springfield Illinois: 751–755
- 14.Natelson, S., Thomas, C.C. (1971) In techniques of Clinical Chemistry 3rd ed., Publisher Springfield Illinois: 162–165
- 15.Fabianek J., DeFilippi J., Rickards T., Herp A. Micromethod for tocopherol determination in blood serum. Clin. Chem. 1968;14:456–62. [PubMed] [Google Scholar]
- 16.Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Annal. Biochem. 1979;95:351–353. doi: 10.1016/0003-2697(79)90738-3. [DOI] [PubMed] [Google Scholar]
- 17.Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.L. Homeostasis model assessment; Insulin resistance and â cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–419. doi: 10.1007/BF00280883. [DOI] [PubMed] [Google Scholar]
- 18.Bierman E.L. George Lyman Duff Memorial Lecture: Atherogenesis in diabetes. Arterioscler. Thromb. 1992;12:647–656. doi: 10.1161/01.atv.12.6.647. [DOI] [PubMed] [Google Scholar]
- 19.Keaney J.F., Loscalzo J. Diabetes, Oxidative Stress, and Platelet Activation. Circulation. 1999;99:189–191. doi: 10.1161/01.cir.99.2.189. [DOI] [PubMed] [Google Scholar]
- 20.Esterbaur H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free. Rad. Biol. Med. 1992;13:341–391. doi: 10.1016/0891-5849(92)90181-F. [DOI] [PubMed] [Google Scholar]
- 21.Ford S.E., Mokdad A.H., Giles W.H., Brown D.W. The Metabolic syndrome and antioxidant concentrations. Diabetes. 2003;52:2346–2352. doi: 10.2337/diabetes.52.9.2346. [DOI] [PubMed] [Google Scholar]